{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:03:39Z","timestamp":1780297419382,"version":"3.54.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.braindev.2026.104542","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:19:16Z","timestamp":1777735156000},"page":"104542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful management of withdrawal symptoms from long-term intravenous dexmedetomidine using guanfacine in a pediatric patient: a case report"],"prefix":"10.1016","volume":"48","author":[{"given":"Kentaro","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Okanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2026.104542_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4212\/cjhp.v66i1.1208","article-title":"Safety and effectiveness of dexmedetomidine in the pediatric intensive care unit (SAD-PICU)","volume":"66","author":"Carney","year":"2013","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.braindev.2026.104542_bb0010","first-page":"453","article-title":"Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children","volume":"22","author":"Haenecour","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.braindev.2026.104542_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0960327112454896","article-title":"Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: report of cases and review of the literature","volume":"32","author":"Kukoyi","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.braindev.2026.104542_bb0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/phar.1559","article-title":"Transition from dexmedetomidine to enteral clonidine for ICU sedation: an observational pilot study","volume":"35","author":"Gagnon","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.braindev.2026.104542_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/2050312115621767","article-title":"Evaluating the transition from dexmedetomidine to clonidine for agitation management in the intensive care unit","volume":"3","author":"Terry","year":"2015","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.braindev.2026.104542_bb0030","article-title":"Effects of a clonidine taper on dexmedetomidine use and withdrawal in adult critically ill patients-a pilot study","volume":"2","author":"Bhatt","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.braindev.2026.104542_bb0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ajhp\/zxaa013","article-title":"Clonidine as a strategy for discontinuing dexmedetomidine sedation in critically ill patients: a narrative review","volume":"77","author":"Glaess","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.braindev.2026.104542_bb0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/1089253218768537","article-title":"Enteral guanfacine to treat severe anxiety and agitation complicating critical care after cardiac surgery","volume":"22","author":"Srour","year":"2018","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.braindev.2026.104542_bb0045","article-title":"Effect of enteral guanfacine on dexmedetomidine use in the ICU","volume":"4","author":"Fetters","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.braindev.2026.104542_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/08971900241263171","article-title":"Alpha2 agonist use in critically ill adults: a focus on sedation and withdrawal prevention","volume":"38","author":"Schuler","year":"2025","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.braindev.2026.104542_bb0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-025-01434-x","article-title":"Guanfacine use in the ICU for management of sedation weaning","volume":"45","author":"Lee","year":"2025","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.braindev.2026.104542_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PCC.0000000000002889","article-title":"Weaning dexmedetomidine in non-ICU areas: an implementation effort","volume":"23","author":"Solodiuk","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2026.104542_bb0065","first-page":"848","article-title":"Attention deficit hyperactivity disorder","volume":"55","author":"Yamashita","year":"2023","journal-title":"Shoni naika (Tokyo)"},{"key":"10.1016\/j.braindev.2026.104542_bb0070","series-title":"INTUNIV (guanfacine) extended-release tablets, for oral use [prescribing information]","author":"Shire US Inc.","year":"2019"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:49:22Z","timestamp":1780296562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760426000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0387760426000434"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104542","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful management of withdrawal symptoms from long-term intravenous dexmedetomidine using guanfacine in a pediatric patient: a case report","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104542"}}